Guangdong Biolight Meditech Co., Ltd.

Equities

300246

CNE1000015Q4

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.55 CNY +0.92% Intraday chart for Guangdong Biolight Meditech Co., Ltd. +5.48% -36.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Guangdong Biolight Meditech Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI
Guangdong Biolight Meditech Co., Ltd. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Guangdong Biolight Meditech Co., Ltd. authorizes a Buyback Plan. CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guangdong Biolight Meditech Co., Ltd. Approves 2022 Profit Distribution Plan, Payable on 25 May 2023 CI
Guangdong Biolight Meditech Co., Ltd. Proposes Final Dividend for 2022 CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Guangdong Biolight Meditech Co., Ltd. Approves Executive Elections CI
Guangdong Biolight Meditech Co., Ltd. entered into an agreement to acquire 51% stake in Sanyuan Fusheng Medical Devices Co., Ltd from Shaanxi Fusheng Medical Products Co., Ltd. for CNY 6.5 million. CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shenzhen Baoyuan Medical Devices Co., Ltd. announced that it has received CNY 25 million in funding from Guangdong Biolight Meditech Co., Ltd. CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guangdong Biolight Meditech Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 11 July 2022 CI
Shenzhen Baoyuan Medical Devices Co., Ltd. announced that it expects to receive CNY 25 million in funding from Guangdong Biolight Meditech Co., Ltd. CI
Guangdong Biolight Meditech Co., Ltd. Approves 2021 Profit Distribution Plan CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guangdong Biolight Meditech Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Medical Devices Maker Biolight Raises $83 Million From Share Placement MT
Guangdong Biolight Meditech Co., Ltd. announced that it has received CNY 539.999995 million in funding from Sichuan Guojing Capital Holding Co., Ltd., UBS AG, China Asset Management Co., Ltd., CCB Principal Asset Management Co., Ltd. and other investors CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Guangdong Biolight Meditech Co., Ltd.
More charts
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300246 Stock
  4. News Guangdong Biolight Meditech Co., Ltd.
  5. Medical Devices Maker Biolight Raises $83 Million From Share Placement